PRODIGIOUS EFFORTS TO EXAMINE the relevant mechanisms involved in skeletal muscle fatigue have begun to focus on Ca 2ϩ handling within the active muscle cell. It is understood that precise control of intracellular Ca 2ϩ is central to optimal performance of skeletal muscle. First and foremost, activator Ca 2ϩ released from the sarcoplasmic reticulum (SR) regulates cross-bridge interactions and thus controls force production. Reductions in SR Ca 2ϩ release will primarily compromise tension development through reduced Ca 2ϩ transients (49, 137, 140) . Second, Ca 2ϩ -activated tension and SR Ca 2ϩ accumulation via the SR Ca 2ϩ -ATPase consume a large fraction of the energy expenditure within the muscle cell (105) . Thus regulation of intracellular Ca 2ϩ fluxes can greatly influence muscle cell metabolism and may possibly serve as a link between the requirement for force and the metabolic state of the active muscle cell.
Eberstein and Sandow (43) first suggested inhibition of Ca 2ϩ release from the SR as a likely and relevant factor in the fatigue process under certain experimental conditions. This has been confirmed time and time again by several different groups in a wide variety of species. Reductions in Ca 2ϩ release have been noted in single muscle fibers from mouse (6) , single whole (136) and cut fibers from frog (64) , and whole bullfrog muscle (10) . Moreover, inhibition of SR Ca 2ϩ release was noted in the rat after it run to exhaustion (46) . (For a more detailed account of the muscle preparations and fatigue protocols please see Refs. 49, 131, 133, and 137.)
Inadequate or suboptimal delivery of Ca 2ϩ to the myofilaments via SR Ca 2ϩ release could occur under three scenarios: 1) impaired coupling between the voltage sensors in the t-tubule (TT) membrane and the SR Ca 2ϩ channel [excitation-contraction coupling (ECC)], 2) reductions in or modification of the SR Ca 2ϩ content, or 3) by transient modification of the SR Ca 2ϩ channel, reducing its opening probability after activation (64, 137) .
It is difficult to assess the contributions of the first hypothesis, considering that the complete mechanism for ECC has yet to be adequately defined. However, Gyorke (64) has suggested that fatigue from tetanic stimulation does not modify function of the t-tubule voltage sensor and is localized to the SR Ca 2ϩ channel.
It is possible that SR Ca 2ϩ content becomes diminished, considering that the catalytic activity of the SR Ca 2ϩ -ATPase is inhibited by a single bout of muscle activity (22, 78, 135) or that ''releasable'' Ca 2ϩ may be buffered by luminal phosphate that becomes elevated in skeletal muscle undergoing activity (55, 103, 132) . This area will be addressed in BIOPHYSICAL REGULATION OF SR Ca 2ϩ RELEASE.
Clearly, the most studied and well-supported contention suggests that activity-induced reductions in myoplasmic Ca 2ϩ transients are mediated by the SR Ca 2ϩ channel and/or its related regulatory proteins. An early observation by Eberstein and Sandow (43) showed that the application of caffeine, a Ca 2ϩ -channel agonist, reversed the loss of force production in fatigued fibers.
This result, confirmed many times (58, 62, 87, 98) , pointedly implicates modification of the SR Ca 2ϩ channel during fatiguing protocols.
Whereas SR Ca 2ϩ channel dysfunction may not be the only cause of fatigue under all conditions of muscle activity, it is considered a viable mechanism for a several different muscle activation patterns. A myriad of studies have demonstrated alterations in myoplasmic Ca 2ϩ during and/or after muscle activity. More complete reviews detailing the various fatigue protocols as well as contributions from the myofilaments and the influence of metabolism have been expertly reviewed elsewhere (49, 120, 137, 140) . In light of these works, this review seeks to accomplish two related goals: 1) to provide an up-to-date molecular understanding of the Ca 2ϩ release process, with considerable attention devoted to the SR Ca 2ϩ release channel, its associated proteins, and channel regulation by endogenous compounds; and 2) to examine several putative mechanisms by which cellular alterations resulting from intense and/or prolonged contractile activity will modify SR Ca 2ϩ release. This review is not intended to be a complete account of the many studies produced over the past decade. Thus apologies are extended for the exclusion of any work that supports this current undertaking.
ECC AND THE SR CHANNEL
ECC is a sequential process that begins with activation of the muscle cell membrane and concludes with Ca 2ϩ -activated tension produced by the myofilaments. Several key proteins participate in this process: the dihydropyridine (DHP) receptor, triadin, a 12-kDa FK506-binding protein (FKBP12), calsequestrin, calmodulin, junctin, and the SR Ca 2ϩ -release channel-ryanodine receptor (RYR).
DHP receptor. The skeletal muscle DHP receptor is an oligomeric complex composed of five different subunits (␣1, ␣2, ␤, ␦, and ␥) (27) . All five subunits have cytoplasmic domains, yet the ␣1-subunit appears to be the most important. It contains the binding site for DHPs and other antagonists and also can form an L-type Ca 2ϩ channel (26) , but Ca 2ϩ entry is not required for activation of the SR Ca 2ϩ -release channel. It is currently believed that the DHP receptors found within the t tubule serve as the voltage sensors associated with asymmetric charge movement, an event consistent with depolarization to the contractile threshold (109) . The ␣1-subunit consists of four repeats with three cytoplasmic loops between each segment (27) . The II-III loop has been postulated to have a role in communication between the DHP and RYR receptors, as peptide fragments from the II-III loop of the DHP receptor bound to and activated the purified skeletal RYR Ca 2ϩ channel but had no effect on the cardiac receptor (90) . Both the ␣1-and ␤-subunits contain multiple sites for phosphorylation that may be critical during muscle activity. The functions of the other subunits have not been fully defined.
Triadin. Several proteins have been localized in the triadic region and are thought to participate in the interaction between the DHP receptor and the SR Ca 2ϩ -release channel; among them, triadin, a 95-kDa glycoprotein, has been the most thoroughly studied (19, 20) . The most compelling evidence arguing for its participation in ECC is that triadin binds to both the RYR channel and the DHP receptor in protein overlay studies, although no reports of direct in vivo interactions have been published (79) . In other studies, triadin has been shown to directly interact with the RYR Ca 2ϩ channel via hyperreactive thiols when the channel is in the open configuration (92) . Cloning of a protein that appears to be identical to triadin (80) indicates that the protein contains one transmembrane domain and a large luminal component. The luminal region contains a number of positively charged residues and may serve as an anchoring protein for calsequestrin, the moderate affinity-high capacity Ca 2ϩ -binding protein that has been implicated in modifying SR Ca 2ϩ release (69) . Continued work should elucidate a more concrete role for triadin.
FKBP12. Four low-molecular-weight binding proteins are associated with each functional RYR channel. These FKBPs function as receptors for the immunosuppressant drugs, FK506 and rapamycin. When these drugs are added to muscle fiber or SR preparations, they induce dissociation of the FKBP12 proteins and appear to reduce or relieve channel inhibition by Mg 2ϩ (4), H ϩ (127), and possibly millimolar Ca 2ϩ (42) . In single-fiber experiments, removal of FKPB12s by rapamycin potentiated Ca 2ϩ release evoked by depolarization or caffeine application (86) . Interestingly, repeated depolarizations resulted in an irreversible loss of depolarization-induced release but not caffeine-induced activation of the release channel. Although the removal of these proteins appears to affect native channel function, it is not known how the proteins participate in normal channel gating or are modified by extended contractile activity.
Calmodulin. Calmodulin is a cytoplasmic Ca 2ϩ -dependent protein that shares many similarities with troponin (28) . Upon binding up to four Ca 2ϩ , the Ca 2ϩ -calmodulin complex can control a large number of calmodulin-dependent enzymes and membrane transport proteins. By binding to the skeletal muscle RYR protein, calmodulin has been shown to modulate channel activity (129) . At low Ca 2ϩ concentration (submicromolar), calmodulin stimulates Ca 2ϩ flux and increases single-channel gating activity (129) . At micro-to millimolar concentrations, calmodulin inhibited the RYR severalfold, thus suggesting that calmodulin may play a role in both activation and inhibition of SR Ca 2ϩ release (129) .
Calsequestrin. Calsequestrin is a low-affinity, highcapacity Ca 2ϩ -binding protein that resides within the SR lumen. It has been shown to be anchored to the junctional SR membrane, thus ensuring a large quantity of Ca 2ϩ near the release channel (35) . It does not bind to the RYR, but has been shown to bind to triadin (63) and has been implicated in modifying Ca 2ϩ release from the SR (39, 69) .
Junctin. Junctin was first discovered in canine heart muscle and later in skeletal muscle (76) . Amino acid sequencing reveals that, like triadin, it resides on the luminal side of the SR membrane (76) . It has recently been shown to bind to triadin, calsequestrin, and the RYR protein (145) (123) . Originally isolated as the junctional foot protein (77) , it was later determined to be the SR Ca 2ϩ -release channel from morphological and pharmacological studies with ryanodine (70, 94, 102) . Because the protein has been identified by different methods, it has acquired several names that are frequently used interchangeably. The skeletal muscle RYR is a highmolecular-weight homotetramer containing four subunits. The monomeric protein contains 5,035 amino acids, with an apparent molecular mass of 560 kDa (124) . The native protein that has been visualized by electron microscopy appears as a quatrefoil structure (cloverleaf-like) (104) . Sequence analysis suggests the presence of cytoplasmic Ca 2ϩ , calmodulin, and adenine nucleotide binding as well as phosphorylation sites.
Three mammalian isoforms have been identified and are encoded by three different genes, ryr1, ryr2, and ryr3. The RYR1, RYR2, and RYR3 proteins correspond to the skeletal, cardiac, and brain isoforms, respectively, the order in which they were identified. Brain tissue contains small amounts of the skeletal and cardiac forms as well as its native protein, whereas the muscle forms predominate in their respective tissues (65) . A more extensive and detailed discussion of this protein has been published by Coronado et al. (34) .
Physical arrangement of proteins. Morphological analysis using immunolabeling and electron microscopic studies revealed that the DHP receptor and RYR-Ca 2ϩ channel were localized in the triadic (two terminal cisternae abutted up to one t tubule) region of mammalian skeletal muscle. The most simplistic arrangement for purposes of ECC would suggest that every DHP receptor reside directly opposite a RYRCa 2ϩ channel. This, however, does not appear to be the case. Four particle clusters, or tetrads, thought to represent four DHP receptors, were located opposite and within close proximity (10-15 nM) to every second junctional RYR, creating a checkerboard pattern and revealing a possible direct link between at least onehalf of the RYRs (16) . Recent work also suggests that as many as 20% of RYRs have been located outside the specific triad area, but their function has not been determined (40) . The aforementioned proteins such as triadin, calsequestrin, FKBP12, and junctin are believed to be localized near the RYR foot structure, but the exact placement and consequent function of these proteins remain obscure. In addition, two glycolytic enzymes, glyceraldehyde 3-phosphate dehydrogenase and aldolase, co-sediment with triad-enriched SR vesicles (25, 66) .
Despite the advances in mapping the triadic region of skeletal muscle, clarity has not been achieved (52) . Moreover, our current understanding of the ultrastructural map does not provide much information as to the accessibility of the triadic space by diffusable mediators that may modify function. For example, single-channel analysis suggests that alterations in the H ϩ concentrations can significantly alter channel gating (110) . However, this result is not confirmed in single-fiber studies with intact t tubules, where pH manipulations had no effect on SR Ca 2ϩ release (31, 84) . Accurate determination of the biophysical architecture leading to a better understanding of its pharmacological and biochemical constraints should provide a more complete list of those metabolites that participate in the SR Ca 2ϩ -release process during muscle activity. The ECC processes are different between mammalian skeletal and cardiac muscle. In heart tissue, the DHP receptor, an L-type Ca 2ϩ channel embedded in the t-tubule membrane, mediates the influx of Ca 2ϩ following an action potential and voltage-dependent activation. The influx of extracellular Ca 2ϩ into the region of the closely opposed SR Ca 2ϩ channels then induces a large increase in intracellular Ca 2ϩ mediated by the SR channel (138) . This process is well defined and has been aptly named calcium-induced calcium release (CICR). In skeletal muscle, Ca 2ϩ entry is not required to activate the SR Ca 2ϩ -release process, as chelation of t-tubule Ca 2ϩ does not prevent activation of the RYR channel and SR Ca 2ϩ release (8, 41) .
CURRENT THEORIES IN ECC
In skeletal muscle, a mechanical coupling was proposed by Schneider and Chandler (113), as they suggested that charged molecules located in the t-tubule membrane move during depolarization, and these molecules provide a physical link between the t tubule and the SR Ca 2ϩ -release process. They observed that voltagedependent charge movement was closely associated with muscle contraction and could be measured across the t-tubule membrane when all ionic currents were blocked. Subsequent experiments showed that DHPs blocked charge movements and SR Ca 2ϩ release with similar voltage and dose dependencies, thus arguing for a critical role of the DHP receptor in the activation of Ca 2ϩ release (109) . This sequence was later confirmed, as dysgenic myotubes lacking the DHP receptor ␣1-subunit failed to elicit requisite charge movement 473 INVITED REVIEW and ECC (11) . This coupling was restored following transfection of the ␣1-unit (123, 125) .
The current hypothetical mechanism suggests a direct interaction between the DHP-receptor tetrads and its closely associated RYR proteins, where voltagedependent activation of the DHP-receptor proteins triggers Ca 2ϩ efflux via the RYR (109) . As Ca 2ϩ exits the mouth of the channel, it putatively diffuses laterally to the unlinked RYR channels providing a role for Ca 2ϩ ion activation or potentiation of the release process (109) . Myoplasmic Ca 2ϩ rises rapidly from ϳ50 nmol/l to 1-5 µmol/l, a concentration great enough to saturate the troponin-binding sites allowing interaction between actin and myosin.
The RYR displays a biphasic Ca 2ϩ -dependent behavior as submicromolar Ca 2ϩ potentiates Ca 2ϩ channel opening while millimolar Ca 2ϩ induces closing of the RYR channel. Ca 2ϩ ions in ECC and SR release have received much interest (96) . Ca 2ϩ has long been proposed as an activator in the Ca 2ϩ -release process, as the increases in myoplasmic Ca 2ϩ after depolarization are thought to produce a positive-feedback CICR. This may be the critical trigger for those channels not directly coupled to t-tubule voltage sensors (109, 143) . Inhibition of RYR activity at high concentrations of Ca 2ϩ has been suggested to close the RYR after activation (109) . However, this hypothetical mechanism does not explain how the SR channel maintains its closed configuration as the myoplasmic or triadic Ca 2ϩ concentrations are lowered back to nanomolar level during SR Ca 2ϩ -ATPase sequestration following cessation of excitation. Although Ca 2ϩ ions may not be the direct trigger of SR Ca 2ϩ release, it is difficult to rule out the possible contributions they may have to potentiating SR Ca 2ϩ release in vivo or under conditions of prolonged contractile activity.
Recently, Stephenson et al. (120) have argued an important role for Mg 2ϩ in regulation of SR Ca 2ϩ release. Their model suggests that by binding to the low-affinity Ca 2ϩ -binding site, Mg 2ϩ (1 mM) exerts a strong inhibitory effect on channel activity, essentially closing the channel during resting conditions (85) . They propose that ''coupling'' between the DHP receptor and RYR induces dissociation of Mg 2ϩ , via FKBP12 participation, removing the inhibition allowing Ca 2ϩ to exit the channel and thus more fully activating the RYR and its neighboring unlinked RYRs (85) . Under their assertion, Ca 2ϩ release is controlled by the voltage sensors on the DHP receptor that regulate Mg 2ϩ binding and dissociation from the RYR channel.
It has also been proposed that endogenous sulfhydryl (SH) groups present on the RYR protein may be responsible for regulating the gating of the SR Ca 2ϩ -release channel (1, 111, 112) . It has been demonstrated that oxidation of the SH groups stimulates SR Ca 2ϩ release in vesicle experiments (2) and muscle fibers (112) . Whereas no clear role for the SH regulation has been established, it remains a viable mechanism to modulate channel gating.
Despite considerable effort over the past decade, the mechanism that describes SR Ca 2ϩ channel activation is unknown. Although the DHP receptor is voltage regulated, the SR Ca 2ϩ channel does not display voltage sensitivity, nor does it appear to be electrically coupled to the DHP receptor. Several hypotheses have suggested that various proteins participate in this process. Roles for triadin and the II-III cytoplasmic loop from the DHP receptor ␣1-subunit have been proposed but not completely elucidated.
In summary, the following sequence of events is currently thought to explain ECC: 1) sarcolemmal action potential, 2) TT charge movement, 3) coupling of TT charge movement to the SR Ca 2ϩ -release channel, 4) Ca 2ϩ release from the SR, 5) Ca 2ϩ binding to troponin, and 6) actomyosin ATP hydrolysis and crossbridge cycling. As discussed above, because sequestration of Ca 2ϩ ultimately restores the Ca 2ϩ gradient, thus ''loading'' the SR membrane, the uptake of Ca 2ϩ may be included as an accessory part of the ECC mechanism.
SR CA 2ϩ RELEASE FROM AN EXPERIMENTAL PERSPECTIVE
When evaluating SR Ca 2ϩ channel function, it is important to understand and evaluate the techniques from which the data were derived. Much of our current understanding regarding channel function was elucidated through the application of three different techniques (discussed below). Concurrent with the development and application of techniques used to study channel function was the identification of a variety of chemical modulators that can regulate the RYR Ca 2ϩ channel activity. The list of activators of SR Ca 2ϩ release includes anthraquinones, halothane, fatty acid derivatives, ryanodine, Ca 2ϩ , adenine nucleotides, caffeine, oxidizing reagents such as hydrogen peroxide, and sulfhydryl reagents (see Table 1 for specific concentrations). Paralleling the list of activators was the identification of compounds that inhibit Ca 2ϩ release. Among them are the polycationic dye ruthenium red; lactate, both Ca 2ϩ and Mg 2ϩ in the millimolar range; and reducing agents, such as dithiothreitol and glutathione. Whereas many of these compounds are not physiological, several have proved extremely useful in describing channel regulation following physiological modification. In particular, experiments with caffeine and ryanodine have led to descriptions of channel behavior that is much like a ''fingerprint,'' indicative of a certain type of channel dysfunction. As these reagents become more widely utilized, our ability to detect important, and yet subtle, changes in channel function will be advanced. Vesicle flux assays. The majority of the early studies examined SR Ca 2ϩ release by using isolated SR vesicle preparations (2, 94, 111) . These vesicles could be actively loaded in the presence of Ca 2ϩ and ATP, developing a 3,000-fold Ca 2ϩ gradient across the SR vesicle. Once loaded, a wide variety of reagents can be used to trigger Ca 2ϩ efflux. SR vesicle flux experiments are advantageous because they closely parallel in vivo Ca 2ϩ release, as a large gradient provides the driving force for release. Triad preparations can also demonstrate activation by t-tubule depolarization following ionic substitution (7) . The greatest advantage of this assay is that it yields representative data by averaging the kinetic behavior of a considerable number of channels contained by the vesicles. However, several drawbacks detract from the global utility of this assay. SR isolation is time consuming, it is possible that key SR proteins are lost as a result of the lengthy procedure, and, last, these assays do require significant amounts of protein, usually requiring larger muscle samples (ϳ1 g muscle needed to isolate SR, the yield is ϳ1 mg/g muscle). Furthermore, because the assays are performed under ''active'' loading conditions where extracellular Ca 2ϩ is monitored, it is possible that reagents that affect Ca 2ϩ -ATPase activity or modify membrane permeability can influence Ca 2ϩ movements independent of SR Ca 2ϩ release. For example, it is very difficult to perform SR Ca 2ϩ release assays at different H ϩ concentrations, as Ca 2ϩ loading is significantly inhibited at lower pH values, thus reducing the driving force for SR release.
Ryanodine-binding assays. Our greatest understanding of release channel regulation was advanced by the development of the ligand-binding assay using tritiated ryanodine (50, 94, 102) . Ryanodine is a neutral plant alkaloid and a naturally occurring insecticide (72) that binds with nanomolar affinity to open Ca 2ϩ channels. The greatest benefit of this assay is that ryanodine binds specifically to its receptor (the RYR-release channel) and to no other protein in the SR. With few exceptions, compounds that activate the SR Ca 2ϩ channel and stimulate Ca 2ϩ release also enhance the binding of ryanodine. The opposite is true for Mg 2ϩ , as it reduces SR Ca 2ϩ release in a concentration-dependent manner and inhibits the binding of the ryanodine to its receptor. These macroscopic assays are not technically difficult, and they provide ample opportunity to manipulate a wide variety of conditions that would be difficult to carry out in flux assays. However, the binding is quite slow (typically 3 h) and thus it does not provide temporal data consistent with SR Ca 2ϩ release in single-fiber or vesicle experiments.
Single-channel analysis. By fusing isolated SR vesicles to lipid bilayer membranes, the SR Ca 2ϩ gating characteristics can be evaluated (117) . Much of the pharmacological and biochemical data generated from the two macroscopic assays have been confirmed on the single-channel level by using isolated proteins. The fused protein remains sensitive to almost all of the known activators and inhibitors of Ca 2ϩ release and ryanodine binding. The channel is permeable to both mono-and divalent cations, but because the channel is almost three times more permeable to Cs ϩ than Ca 2ϩ , Cs ϩ is frequently used as the charge carrier. Following fusion and incorporation of the Ca 2ϩ -release channel into the bilayer membrane, both the cytoplasmic and luminal sides of the channel protein can be manipulated. This technique is technically demanding, but direct access to a single-gating channel can provide important and detailed information on a molecular level. However, this technique may be self-limiting where macroscopic assays might provide more conclusive data. For example, it was previously determined that SR Ca 2ϩ release was reduced by 30% after a run to exhaustion in rats (46) . It is believed that as few as one RYR channel exists per vesicle (some vesicles contain no channels), and if only 30% of the channels are dysfunctional, it is possible that 70% of the fusion events will contain unmodified RYR proteins. Thus many assays would have to be conducted to ensure that the stated effect was observable at the single-channel level. Still, this technique was used to determine the Ca 2ϩ sensitivity of gating RYR channels isolated from denervated rat muscle (38) . In the native state, Ca 2ϩ channel experiments are performed as many as six to ten times to confirm channel behavior.
The physiological relevance of the above biochemical and pharmacological characterizations have been advanced and clarified in single-fiber studies. From these studies, it appears as if the Ca 2ϩ -release process may be dually regulated (85) . DHP receptor-mediated activation exerts the most important control over the SR Ca 2ϩ -release process. However, modulation of SR Ca 2ϩ release can be accomplished through a variety of reagents that are known to stimulate or inhibit RYR activity. Considering this evidence, it is important to evaluate reagents typically used in both biochemical and various fiber preparations. Some, but not all, ligands that modulate RYR channel activity in SR vesicle experiments perform similarly at the level of a single muscle fiber. Lamb and Stephenson (85) , using skinned fibers with intact TT, have shown that after a normal depolarization Ca 2ϩ release and muscle contraction could be completely inhibited by high Mg 2ϩ concentrations, a result consistent with SR vesicle studies (95) . They demonstrate that the function of the SR Ca 2ϩ channel is controlled by the TT under resting conditions but it is also sensitive to the changing intracellular milieu. On the other hand, in a different study, Lamb et al. (84) Whereas it is theoretically possible that the channel conductance may be modified, this scenario is unlikely during fatigue. There are very few examples in which conductance has been modified by anything other than nonbiological organic molecules. Ryanodine can induce subconductance states in single-channel experiments (68, 82) . Furthermore, subconductance behavior was also recently reported after the removal of FKBP12 by rapamycin (4), but this was also accompanied by an increase in the P o , making it difficult to extrapolate these results to conditions of muscle fatigue.
Recent work indicates that the SR lumen/cytoplasmic Ca 2ϩ gradient may become diminished as a result of either inadequate refilling following Ca 2ϩ release or by reducing the amount of free releasable Ca 2ϩ stored within the lumen.
The total SR Ca 2ϩ content has been determined to be 1-2 mM per fiber volume (51, 55) and represents the driving force for Ca 2ϩ release into the myoplasm. Fryer et al. (56) have indicated that SR Ca 2ϩ content is different between fast and slow type muscle. Luminal Ca 2ϩ content is dependent on several factors including, but not limited to, function of the SR Ca 2ϩ ATPase, leakiness of the SR membrane and/or RYR channel, and the total amount of Ca 2ϩ released that is a function of duration and frequency of the contractile protocol. Inhibition of the SR ATPase (22, 91) and reductions in Ca 2ϩ accumulation by SR have been demonstrated after exhaustive running in rats (22, 78) , in single-fiber experiments (135, 141) , and in exercising humans (17) . Evidence suggests that with prolonged stimulation resting intracellular Ca 2ϩ concentrations are significantly elevated (89) . However, one early report suggested that SR Ca 2ϩ content is not modified (61) .
Reductions in the amount of releasable SR Ca 2ϩ due to the formation of a Ca 2ϩ -P i precipitate would also decrease SR Ca 2ϩ release, as has been suggested by Fryer et al. (55) . P i can rise to 30-40 mM in the active muscle cell (23), a concentration sufficiently high enough for P i to enter the SR and complex with Ca 2ϩ forming a precipitate (57) . Recent work from Fryer et al. (55, 57) and Westerblad and Allen (132) indicates that physiological concentrations of P i will reduce force by decreasing SR Ca 2ϩ release, an event whose time course of recovery is consistent with the resolubilization of the Ca 2ϩ -P i precipitate (103) . Continued work in this area should reveal more evidence detailing the implications of reduced SR Ca 2ϩ content and/or the effects of P i on SR Ca 2ϩ concentrations during muscle fatigue. Further study should help to clarify the effect of prolonged contractile activity on SR Ca 2ϩ load and loading parameters.
FAILURE OF SR CA 2ϩ RELEASE AND MUSCLE FATIGUE
Intense or prolonged contractile activity can reduce muscle force output that recovers after the cessation of activity. This sequential pattern of events is typically referred to as muscle fatigue. In part, the length of the recovery period is one of several characteristics that distinguish different types of fatigue, in particular, low-frequency fatigue (LFF) and high-frequency fatigue (HFF) (74, 75) . HFF is characterized by a rapid loss of force that recovers very quickly once muscle activation is reduced or stopped (75) . It has been suggested that HFF is most likely due to disturbances in muscle excitation related to ionic imbalances that are readily reversible (24, 75) . It has been questioned whether this type of fatigue is normal in healthy muscle (75) . Conversely, LFF, first described by Edwards et al. (44) , is characterized by a loss of force primarily at lower stimulation frequencies, from which recovery is slow and may persist for hours or days, despite the absence of any gross disturbances in the muscle (75) . It is important to point out that this type of fatigue can be caused by a variety of forms of activity, but loss of force is noticeable at lower stimulation frequencies. It has been suggested that LFF may be due to a wider variety of mechanisms including, but not limited to, metabolic, mitochondrial, and/or SR disruptions. Despite the fact that the etiology of muscle fatigue is very dependent on that stimulation frequency or muscle activation protocol, along with other considerations such as fiber type, state of training, etc., SR Ca 2ϩ release remains a focal point.
The type of stimulation protocol that is most like prolonged submaximal exercise is LFF. Fatigue induced by low-frequency stimulation tends to follow a stereotypical pattern of force decline (133) . During the initial phase, force declines rapidly to ϳ80% of control. During the second phase, a more stable force production pattern predominates, with a slight additional reduction in force to 70%. This is followed by a rapid decline of force to ϳ30-40% and is referred to as ''phase three.'' It has long been suggested that reductions in SR Ca 2ϩ release were involved in loss of force observed at low stimulation frequencies (44) and are suggested to be the primary factor in phase-three fatigue (133 (83) have shown that raised intracellular Ca 2ϩ in skinned fibers abolishes ECC and alters the structure of the t-tubule SR triad. Reductions in Ca 2ϩ release after exposure to 100 µM Ca 2ϩ were noted to be time dependent (longer exposures induce greater uncoupling), temperature dependent (uncoupling 13-fold slower at 3°C compared with 23°C), and pH dependent (slower at lower pH values). Interestingly, Mg 2ϩ elevated to 10 mM did not prevent or induce uncoupling at high Ca 2ϩ . Whereas these studies focus on ECC as a whole, they do not pinpoint the critical step that is modified by elevated Ca 2ϩ . This, however, was examined by Williams (139) , who recently demonstrated that in skinned frog fibers SR Ca 2ϩ release is directly affected by elevated Ca 2ϩ . A single 5-min exposure to 500 nM Ca 2ϩ , a concentration noted to accompany fatiguing stimulation (135) , reduced caffeine-stimulated SR Ca 2ϩ release. Chin and Allen (29) and Chin et al. (32) have further characterized this phenomenon. Their work suggests that the duration of exposure must be considered along with the level to which intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) is raised, arguing that the ''Ca 2ϩ -time integral'' is most critical in predicting the deficit in SR Ca 2ϩ release induced by raise in intracellular Ca 2ϩ (32) .
It has been suggested that under these conditions Ca 2ϩ release may be modified by proteolytic digestion of key SR proteins. Skeletal muscle contains significant levels of Ca 2ϩ -activated neutral proteases that become active when Ca 2ϩ is elevated. Ca 2ϩ -activated neutral proteases have been shown to cleave the RYR without greatly modifying function (59) and have been noted to be elevated after endurance-type exercise (12) . However, this hypothesis was not supported, as the application of protease inhibitors did not prevent the uncoupling of ECC (29, 83) . The pH and temperature dependence of these effects indicate the possible involvement of an enzymatic element such as Ca 2ϩ -activated protein phosphatases and kinases.
Despite the unknown origin of these observations, the effect of Ca 2ϩ -induced uncoupling may actually serve to preserve the integrity of muscle cells during extreme conditions. Reductions in ECC and Ca 2ϩ release may provide an opportunity to limit releasable Ca 2ϩ while sequestration continues. This would favor a lower Ca 2ϩ environment and reduce Ca 2ϩ -mediated muscle damage (9, 21) . Elevated Ca 2ϩ concentrations during fatiguing exercise need closer examination to determine if and how this event contributes to the decline in muscle performance.
Metabolism within the triadic space (microcompartment). The increase in energy production that accompanies contractile activity can significantly alter the metabolite levels of skeletal muscle. It is believed that part of the reduction in Ca 2ϩ release may be of metabolic origin, since in some cases restoration of normal metabolite levels also restores some of the Ca 2ϩ -activated force. The relationship between metabolites and muscle function is extremely complex. For example, reductions in pH observed during high-intensity, short-duration exercise correlate with the reduction in pH during most fatigue protocols (23, 37) . However, during the ensuing recovery process, tension returns to normal more rapidly than does pH (18) , and the negative effects associated with pH changes have been shown to be less significant as experimental muscle temperature approaches physiological levels (134) . This uncoupling of muscle function from metabolite restoration during the recovery process suggests that muscle fatigue is multifactorial.
One reason for the inconsistency between changes in global cell metabolism and force mediated by SR Ca 2ϩ release may be the architecture of the triadic region. It is possible that any number of physical constraints may prevent diffusable mediators from entering or exiting the tightly controlled space. Moreover, a microcompartment surrounding the SR Ca 2ϩ channel would allow for a more precise regulation of compounds that might modulate, if not control, Ca 2ϩ release. Supporting this contention are the presence of glycolytic enzymes within the triadic space that modify local ATP production (66, 142) and the existence of a microenvironment surrounding the SR Ca 2ϩ -ATPase (81) . Rather than address all of the possible permutations of different metabolites that would be present during a wide variety of muscle activation patterns, I will focus on a few key metabolites that have been shown to affect the SR Ca 2ϩ -release process and concentrations of which are likely to be modified within the triadic space.
Glycogen. Glycogen is tightly associated with SR membranes in skeletal muscle (45, 54) , and its reduction in concentration has long been identified with the onset of muscle fatigue (14) . Glycogen is critical for energy production and carbon flux through glycolysis, but it is not understood how its depletion reduces muscle performance. Due to its association with the SR, glycogen has been proposed to modulate Ca 2ϩ efflux from and sequestration into the SR. Several investigators have shown a reduction in Ca 2ϩ -ATPase activity (13, 22, 78) http://jap.physiology.org/ strated a glycogen-dependent failure of SR Ca 2ϩ release. From their data, they concluded that reductions in muscle glycogen reduced the [Ca 2ϩ ] i and force, suggesting that glycogen availability was important for SR Ca 2ϩ release. After stimulation, fibers incubated in 5.5 mM glucose resynthesized glycogen to control levels and demonstrated an enhanced fatigue resistance compared with fibers incubated in a glucose-free medium. Chin and Allen hypothesize that glycogen localized to the triadic region of skeletal muscle provides a functional coupling between ATP generated by glycolysis and that produced within the triadic gap [see Han et al. (66) , ATP section]. Thus, when triadic glycogen is reduced, SR Ca 2ϩ release and force production are concomitantly reduced, providing a possible communication between the current state of muscle metabolism and the membrane-protein system that regulates intracellular Ca 2ϩ .
It is clear that muscle glycogen is a vital component of metabolism and may provide a functional and structural communication between the SR and the muscle cell during periods of prolonged contractile activity. Continued work to determine a direct link between glycogen and the function of the RYR channel will provide important evidence as to the mechanism by which the depletion in muscle glycogen modifies Ca 2ϩ release in skeletal muscle and reduces contractile performance.
ATP. It has long been suggested that depletion of high-energy phosphates is involved in muscle fatigue (126) . However, much of our current evidence does not support this contention [see Fitts (49) ]. It is currently thought that bulk muscle ATP does not drop significantly before other factors that reduce force production (15) . Still, ATP activates RYR channels (116) , and it has been shown that ATP synthesis and consumption are microcompartmentalized in isolated skeletal muscle triads (66) . The triad-synthesized ATP is not in equilibrium with the overall muscle ATP (66) , suggesting that a depletion of local ATP in the junctional region could affect Ca 2ϩ -release channels, the activity of which is stimulated by ATP. Allen et al. (5) have also demonstrated that caged ATP, when activated by flash photolysis in a fatigued fiber, produced a concentrationdependent increase in tetanic Ca 2ϩ concentration and force. They speculated that an ATPase, the activity of which is compromised by fatigue, resides in the triadic space and is responsible for phosphorylating a protein essential for full activation of ECC (50) . Until additional studies clarify the role of ATP in the ECC process as well as determine its ability to diffuse into and out of the triadic space, this issue will remain incompletely characterized.
Lactate. Lactic acid accumulation has long been considered a potential contributor to muscle fatigue, but it is now generally agreed that the reduction in tension development occurs through the effect of increased H ϩ on cross-bridge formation (33, 88, 97) . However, a recent report indicates that lactate can reduce tension development in working dog muscle (67) . Lactate infused into arterial blood significantly increased muscle lactate concentrations without any decline in arterial or muscle pH. Although initial tension was unchanged after lactate infusion, the continued presence of lactate exacerbated the decline in tension observed during repetitive stimulation (67) . Subsequently, during lactate washout of the muscle, the inhibition of tension development was alleviated. To this end, lactate (30 mM) significantly inhibits SR Ca 2ϩ release by a variety of activators, including Ca 2ϩ , caffeine, hydrogen peroxide, and Ag ϩ (47, 48) . The inhibitory effect of lactate was confirmed in [ 3 H]ryanodine-binding experiments and single Ca 2ϩ channel analysis (47, 48) . Lactate inhibition of Ca 2ϩ channel activity should reduce the amount of Ca 2ϩ released after normal muscle activation. As with Mg 2ϩ , reductions in SR Ca 2ϩ release mediated by lactate most likely follow the rise and fall of lactate levels and would be operative only when lactate is elevated. This is the likely case, as pretreatment of SR vesicles with 30 mM lactate failed to inhibit Ca 2ϩ release when the lactatetreated SR was diluted into a lactate-free flux medium and release experiments were conducted (final lactate concentration Ͻ1 mM, unpublished observations).
Considering the evidence in the previous sections, we can infer that a pool of local metabolites may be responsible for modulating Ca 2ϩ release and thus force production. Beginning with glycogen and the understanding that its reduction correlates with fatigue and ending with modifications in glycolytic intermediates, it is likely that modification of intracellular Ca 2ϩ concentrations by various metabolites may influence the Ca 2ϩ -release process and, ultimately, force production. This follows the notion of Williams and Klug (140) , who argued that control of intracellular Ca 2ϩ concentration is a critical link between muscle activity and fatigue. They suggest that alterations in intracellular Ca 2ϩ handling often precede the decline in force production and thus may function by downregulating the energy cost of contractility. The concomitant reduction in energy usage and force production may be a transient trade-off in order to maintain the structural and functional integrity of the cell.
Mg 2ϩ . Mg 2ϩ is a potent inhibitor of the SR Ca 2ϩ channel, both in isolated SR (95) and in single-fiber experiments (75) . It is believed that Mg 2ϩ and Ca 2ϩ share and compete for common binding sites on the RYR (95, 101) . Mg 2ϩ concentrations rise almost twofold (from 0.86 to 1.55 mM) during tetanic stimulation of mouse muscle fibers (130) . Intracellular Mg 2ϩ concentration could rise as a result of reductions in ATP as Mg 2ϩ binds less strongly to ADP. This possibility is difficult to assess, considering that global ATP concentration in the muscle is most likely unaltered during activity. On the other hand, as intracellular Ca 2ϩ rises, it is buffered by several Ca 2ϩ -binding proteins, including parvalbumin. Ca 2ϩ binds to one of the two divalent cationbinding sites on parvalbumin by displacing Mg 2ϩ (60) . This alone may be significant, considering that parvalbumin concentrations have been reported to be as high as 0.5 mM in some species of muscle cells (60 ROS. ROS have drawn attention because of their potential to disrupt normal muscle function by targeting specific proteins for modification. Molecular oxygenderived intermediates are produced extensively in living tissues undergoing oxidative stress, such as ischemia, reperfusion, and vitamin deficiency (53) . Over a decade ago, the first reports demonstrated that ROS were generated during exercise (36, 71) . Since then, many reports have indicated that free radicals may play a significant role in muscle damage and fatigue that occurs with exhaustive type of exercise (see Refs. 114 and 115 for more extensive reviews).
Free radicals may be generated by several pathways in skeletal muscle (115) . They include the electron transport system, located in the mitochondrial inner membrane system, and the xanthine oxidase enzyme system. The active muscle cell is a highly oxidative environment. At rest, ϳ2-4% of oxygen transport through the mitochondria escapes in the form of free radicals, typically superoxide. Numerous muscle cell scavenger mechanisms, such as superoxide dismutase and catalase, detoxify free radicals. Within the resting cell, the defense mechanisms far exceed the production of free radicals. However, during exercise, mitochondrial oxygen consumption can increase 20-fold, and free radical production may overwhelm the cellular defense mechanisms. Several investigators have measured free radical production as a result of contractile activity either directly or via indirect methods such as marker molecules [see Sen (114) for extensive list].
As stated in the aforementioned section, endogenous SH groups localized to the SR Ca 2ϩ -release channel are thought to play a significant role in its regulation (1) . It is believed that oxidation of SH groups triggers the opening of the SR RYR release channel while reduction of the disulfide bond induces closure of the channel. This theory is supported by the following observations. 1) SR Ca 2ϩ release is potently activated by oxidizing agents and the binding of heavy metals to SH groups localized to the RYR. 2) Oxidation-induced release is sensitive to all of the known modulators of SR Ca 2ϩ release; i.e., it is potentiated by adenine nucleotides, Ca 2ϩ , and caffeine and inhibited by ruthenium red, tetracaine, and reducing agents (3). These results have been confirmed at the single-channel level, and whereas most activators of release are inhibited by Mg 2ϩ at any concentration, SH oxidation-induced release is stimulated by concentrations up to 1 mM (physiological) and inhibited at higher Mg 2ϩ concentrations (1) . Whereas it is unlikely that SH oxidation is the physiological trigger for activation of SR Ca 2ϩ release, our current understanding suggests that it is a viable mechanism for modifying normal ECC during oxidative stress.
The SR Ca 2ϩ -release channel displays redox sensitivity (144) , and exercise-induced alterations in the cell redox environment may modify its function. The redox environment of the active muscle is dependent on the GSH/GSSG ratio. Glutathione, a tripeptide, is one of the most abundant intracellular thiols found in the body. It is a scavenger of free radicals, and in the process it becomes oxidized to GSSG. Within the cytosol, the intracellular ratio of GSH to GSSG is maintained at a relatively high level (range of 5-20:1) and, in part, it determines the oxidation-reduction state in cells. During oxidative stress, such as exercise, this ratio may become altered, inactivating enzymes that bear free SH groups and result in the formation of inter-or intramolecular mixed disulfides. It has been reported that exercise significantly alters the GSH/ GSSG of skeletal muscle excised from animals run to exhaustion (73) . This suggests that not only is the cell redox environment perturbed, possibly by free radicals, it indicates that oxidation does alter the cell thiol status. Thus the RYR channel, which contains sensitive SH groups, appears a likely target for modification. It has been directly demonstrated that the skeletal muscle RYR channel is sensitive to singlet oxygen (122), hydrogen peroxide (48, 99) and hypochlorous acid (128) . Recently, Oba et al. (99) demonstrated that hydrogen peroxide initially potentiated twitch tension. This increase was followed by a significant decline over time in single fibers. An interesting theory of ROS-muscle interactions has been proposed by Reid and co-workers (106, 108) . They suggest that ROS are obligatory for normal ECC in skeletal muscle. It was shown that depletion of ROS via the addition of antioxidants depresses the twitch response and contractile function of unfatigued diaphragm muscle. Conversely, during fatiguing stimulation, the removal of ROS slows the fall of force, thus improving contractile performance.
The effects of nitric oxide (NO) on contractile function are rapidly coming into focus (119) . Moreover, because NO reacts with other free radicals, it has become more difficult to evaluate the effects of ROS on in vivo muscle contraction. NO is a short-lived species that can react with molecular oxygen and superoxide anions to generate NO derivatives that can participate in redox reactions (119) . Free thiol groups are the primary targets for NO modification, either by S-nitrosylation or by influencing disulfide formation (118) . It is not surprising to find that NO can target SR Ca 2ϩ -release channels. NO has been shown to inhibit channel opening (3) as well as activate the channel at higher concentrations (3, 121) . This biphasic behavior is directly opposite of that observed when using hydrogen peroxide, where activation occurs at lower concentrations and inhibition of channel openings occurs at increasingly higher concentrations (48) . Aghdasi et al. (3) proposed that lower concentrations of NO protect the Ca 2ϩ -release channel from oxidation, whereas higher concentrations induce intermolecular cross-linking that results in an http://jap.physiology.org/ increase in Ca 2ϩ channel P o . Physiological effects of NO on skeletal muscle and Ca 2ϩ channel regulation have yet to be determined. However, considering the effects on SR Ca 2ϩ channel SH groups, it remains a viable mechanism to influence Ca 2ϩ regulation in muscles undergoing activity.
Despite the significant number of studies that implicate ROS in muscle fatigue and muscle damage, we have only begun to understand the relationship between ROS and muscle function in both the rested and active state. Moreover, because of the ability of NO to react with ROS, it appears that their collective activities may be linked in some manner to control and/or modify Ca 2ϩ regulation in muscle cells.
CRITICAL QUESTIONS
Several areas need to be considered to provide a clearer understanding of any potential mechanism that involves reduced SR Ca 2ϩ release.
1) Proteins.
Continued evaluation of all proteins, existing and emerging, needs to focus on more precise anatomic placement, leading to a more advanced understanding of individual or complex function. A more accurate map of the triadic space should help determine the accessibility of diffusable mediators that may modify SR Ca 2ϩ channel function.
2) Multiple regulators. Many important metabolites have been shown to alter SR Ca 2ϩ channel function, but they are often evaluated independently. Our current knowledge would be greatly extended if experiments were designed to assess how multiple regulators interact with each other and with key triadic proteins.
3) Techniques. What new and emerging techniques will shed light on events that have yet to be described during or following intense prolonged muscle activity? For example, utilization of single-channel analysis or Ca 2ϩ sparks techniques that may provide molecular insights into channel dysfunction.
Conclusions. In light of the fact that the detailed mechanism that describes ECC and SR Ca 2ϩ release in muscle fibers is currently unresolved, our common understanding suggests that a variety of contractile patterns that elicit muscle fatigue appear to involve alterations in ECC and reduced SR Ca 2ϩ release. Several putative mechanisms have been evaluated that represent collective ideas forwarded by many different investigators. Much work has significantly focused the discussion and areas of experimentation regarding SR Ca 2ϩ release and muscle fatigue. A continued synthesis of experimental techniques, from isolated protein experiments involving single-channel analysis to controlled experiments using fiber bundles activated by an intact nerve, should provide further understanding of muscle performance observed during animal or human activity.
